Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Rencofilstat

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Hepion Announces Major Reductions in Liver Stiffness with Rencofilstat Treatment
    Hepion Announces Major Reductions in Liver Stiffness with Rencofilstat Treatment

    13 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/13/2779461/0/en/Hepion-Pharmaceuticals-Announces-Major-Reductions-in-Liver-Stiffness-with-Rencofilstat-Treatment-in-17-week-Phase-2-Study-of-Advanced-F3-MASH-Liver-Disease.html

    GLOBENEWSWIRE
    13 Nov 2023
    Share Share
    Hepion Pharmaceuticals Schedules Conference Call
    Hepion Pharmaceuticals Schedules Conference Call

    10 Nov 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/11/10/2778336/0/en/Hepion-Pharmaceuticals-Schedules-Conference-Call-to-Review-Additional-Efficacy-Data-from-Phase-2-ALTITUDE-NASH-Liver-Function-Trial-of-Rencofilstat.html

    GLOBENEWSWIRE
    10 Nov 2023
    Share Share
    Hepion Pharmaceuticals™ Rencofilstat Demonstrates Anti-Cancer Activity
    Hepion Pharmaceuticals™ Rencofilstat Demonstrates Anti-Cancer Activity

    25 Oct 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/10/25/2766519/0/en/Hepion-Pharmaceuticals-Rencofilstat-Demonstrates-Anti-Cancer-Activity-in-Hepatitis-C-Associated-Cancer-Model.html

    GLOBENEWSWIRE
    25 Oct 2023
    Share Share
    New Anti-Cancer Opportunities Revealed for Hepion Pharmaceuticals™ Rencofilstat
    New Anti-Cancer Opportunities Revealed for Hepion Pharmaceuticals™ Rencofilstat

    21 Sep 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/09/21/2747228/0/en/New-Anti-Cancer-Opportunities-Revealed-for-Hepion-Pharmaceuticals-Rencofilstat-in-Cancer-Screening-Program.html

    GLOBENEWSWIRE
    21 Sep 2023
    Share Share
    Rencofilstat Produces Positive Outcomes in Translational Study
    Rencofilstat Produces Positive Outcomes in Translational Study

    14 Sep 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2023/09/14/2743273/0/en/Rencofilstat-Produces-Positive-Outcomes-in-Translational-Study-on-Idiopathic-Pulmonary-Fibrosis.html

    GLOBENEWSWIRE
    14 Sep 2023
    Share Share
    Hepion Schedules Conference to Review Results from Trial of Rencofilstat
    Hepion Schedules Conference to Review Results from Trial of Rencofilstat

    19 May 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/05/19/2672786/0/en/Hepion-Pharmaceuticals-Schedules-Conference-Call-to-Review-Topline-Results-from-Phase-2-ALTITUDE-NASH-Liver-Function-Trial-of-Rencofilstat.html

    GLOBENEWSWIRE
    19 May 2023
    Share Share